MAGED4 and central nervous system cancer: Since the MAGED4 promoter contains a CpG island [20], we confirmed, via in vitro promoter methylation and luciferase reporter assays, that promoter methylation suppresses MAGED4 transcriptional activity, consistent with our prior findings in glioma [9,20].